PAPER
Synthesis and Use of 1,3-Benzoxathian Derivatives
3851
Bis[4-methyl-2,6-bis-(3,3,4,4,5,5,6,6,6-nonafluorohexylsulfanyl-
methyl)phenoxy]methane (4d)
MS (EI): m/z (%) = 416 (3) [M+], 295 (22), 294 (100), 293 (88), 279
(39), 237 (9), 91 (9).
Yellow liquid.
Anal. Calcd for C28H32OS: C, 80.72; H, 7.74; O, 3.84; S, 7.70.
Found: C, 80.42; H, 7.66; O, 3.85; S, 7.44.
IR (neat): 2931, 1476, 1355, 1203, 1127, 1074, 965, 845, 749, 697
cm–1.
7c; Minor Diastereoisomer
Pale-yellow solid; mp 120–125 °C.
IR (neat): 2947, 2901, 1438, 1246, 1004, 882, 727, 709, 698 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.08 (s, 4 H, ArH), 5.52 (s, 2 H,
OCH2O), 3.80 (s, 8 H, ArCH2S), 2.75–2.60 (m, 8 H, SCH2CH2),
2.40–2.20 (m, 14 H, SCH2CH2 and CH3).
13C NMR (100 MHz, CDCl3): d = 150.7 (C), 135.2 (C), 131.5 (C),
1H NMR (300 MHz, CDCl3): d = 7.55–7.45 (m, 2 H, ArH), 7.45–
7.15 (m, 9 H, ArH), 6.93 (s, 1 H, ArH), 5.95 (s, 1 H, OCHS), 5.30
(s, 1 H, ArCHAr), 1.45 (s, 9 H, t-Bu), 1.29 (s, 9 H, t-Bu).
2
130.8 (CH), 101.2 (CH2), 31.7 (t, JC,F = 22 Hz, CH2CF2), 31.1
(CH2), 22.5 (CH2), 20.6 (CH3).
HPLCMS (APCI): m/z (%) = 1397 (40) [M + H+], 705 (100).
13C NMR (100 MHz, CDCl3): d = 151.7 (C), 145.2 (C), 142.4 (C),
138.7 (C), 138.0 (C), 128.61 (CH), 128.58 (CH), 128.4 (CH), 128.3
(CH), 126.9 (CH), 126.7 (CH), 125.5 (CH), 123.6 (CH), 119.6 (C),
77.5 (CH), 46.5 (CH), 35.4 (C), 34.3 (C), 31.5 (CH3), 30.2 (CH3).
+
HRMS (ESI): m/z [M + NH4 ] calcd for C43H40F36O2NS4:
1414.1367; found: 1414.1293.
6,8-Dimethyl-4-phenyl-1,3-benzoxathian (7a)
Pale-yellow solid; mp 103–104 °C.
MS (EI): m/z (%) = 416 (4) [M+], 295 (23), 294 (100), 293 (85), 279
(38), 237 (6), 91 (6).
IR (neat): 2971, 1479, 1203, 1146, 1008, 866, 791, 725, 700, 693
cm–1.
Anal. Calcd for C28H32OS: C, 80.72; H, 7.74; O, 3.84; S, 7.70.
Found: C, 80.61; H, 7.71; O, 3.90; S, 7.60.
1H NMR (400 MHz, CDCl3): d = 7.65–7.10 (m, 5 H, ArH), 6.97 (s,
1 H, ArH), 6.63 (s, 1 H, ArH), 5.31 (d, J = 11.2 Hz, 1 H, OCHHS),
5.24 (s, 1 H, ArCHAr), 5.12 (d, J = 11.2 Hz, 1 H, OCHHS), 2.28 (s,
3 H, CH3), 2.22 (s, 3 H, CH3).
13C NMR (100 MHz, CDCl3): d = 150.1 (C), 143.5 (C), 131.0 (CH),
129.1 (C), 128.8 (CH), 128.4 (CH), 128.3 (CH), 127.5 (C), 127.2
(CH), 120.7 (C), 65.3 (CH2), 44.0 (CH), 20.4 (CH3), 16.4 (CH3).
6,8-Dimethyl-4-phenyl-4H-1-oxa-3-thianaphthalene-3-oxide (8)
White solid; mp 226–229 °C.
IR (neat): 2947, 1479, 1452, 1209, 1148, 1029, 866, 799, 743, 715,
695, 665 cm–1.
1H NMR (300 MHz, CDCl3): d = 7.45–7.30 (m, 3 H, ArH), 7.25–
7.15 (m, 2 H, ArH), 7.04 (s, 1 H, ArH), 6.71 (s, 1 H, ArH), 5.31 (s,
1 H, ArCHAr), 5.04 (d, J = 11.1 Hz, 1 H, OCHHSO), 4.66 (d,
J = 11.1 Hz, 1 H, OCHHSO), 2.34 (s, 3 H, CH3), 2.24 (s, 3 H, CH3).
13C NMR (100 MHz, CDCl3): d = 148.3 (C), 135.8 (C), 132.1 (CH),
131.7 (C), 130.3 (CH), 129.7 (CH), 129.2 (CH), 128.6 (CH), 127.0
(C), 114.2 (C), 72.5 (CH2), 63.8 (CH), 20.5 (CH3), 16.3 (CH3).
GCMS (EI): m/z (%) = 256 (11) [M+], 210 (49), 209 (100), 195
(12), 165 (13), 77 (2).
Anal. Calcd for C16H16OS: C, 74.96; H, 6.29; O, 6.24; S, 12.51.
Found: C, 74.77; H, 6.45; O, 6.29; S, 12.32.
6,8-Di-tert-butyl-4-phenyl-1,3-benzoxathian (7b)
White solid; mp 122–124 °C.
GCMS (EI): m/z (%) = 256 (4) [M+ – O], 210 (49), 209 (100), 195
(9), 165 (11).
IR (neat): 2952, 1491, 1475, 1130, 1021, 881, 795, 756, 747, 720,
696, 676 cm–1.
Anal. Calcd for C16H16O2S: C, 70.56; H, 5.92; O, 11.75; S, 11.77.
Found: C, 70.30; H, 6.15; O, 11.71; S, 11.81.
1H NMR (300 MHz, CDCl3): d = 7.30–7.10 (m, 6 H, ArH), 6.70 (d,
J = 2.4 Hz, 1 H, ArH), 5.20 (d, J = 10.8 Hz, 1 H, OCHHS), 5.18 (s,
1 H, ArCHAr), 4.97 (d, J = 10.8 Hz, 1 H, OCHHS), 1.35 (s, 9 H, t-
Bu), 1.14 (s, 9 H, t-Bu).
6,8-Dimethyl-4-phenyl-4H-1-oxa-3-thianaphthalene-3,3-di-
oxide (9)
White solid; mp 195–197 °C.
IR (neat): 2948, 1480, 1320, 1305, 1125, 1061, 928, 855, 763, 738,
703 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.50–7.40 (m, 3 H, ArH), 7.40–
7.30 (m, 2 H, ArH), 7.01 (s, 1 H, ArH), 6.54 (s, 1 H, ArH), 5.47 (s,
1 H, ArCHAr), 5.01 (d, J = 12.0 Hz, 1 H, OCHHSO2), 4.93 (d, J =
12.0 Hz, 1 H, OCHHSO2), 2.31 (s, 3 H, CH3), 2.20 (s, 3 H, CH3).
13C NMR (100 MHz, CDCl3): d = 148.5 (C), 133.1 (C), 132.3 (CH),
131.7 (C), 131.0 (CH), 129.4 (CH), 128.8 (CH), 128.8 (CH), 128.0
(C), 119.6 (C), 77.2 (CH2), 67.8 (CH), 20.5 (CH3), 16.2 (CH3).
13C NMR (100 MHz, CDCl3): d = 150.8 (C), 143.9 (C), 142.0 (C),
138.4 (C), 128.8 (CH), 128.3 (CH), 127.1 (CH), 125.4 (CH), 123.5
(CH), 120.6 (C), 64.5 (CH2), 44.5 (CH), 35.3 (C), 34.2 (C), 31.5
(CH3), 30.1 (CH3).
GCMS (EI): m/z (%) = 340 (12) [M+], 294 (100), 293 (95), 280
(12), 279 (51), 237 (9), 91 (13).
Anal. Calcd for C22H28OS: C, 77.60; H, 8.29; O, 4.70; S, 9.42.
Found: C, 77.54; H, 8.29; O, 4.66; S, 9.18.
6,8-Di-tert-butyl-2,4-diphenyl-1,3-benzoxathian (7c); Major
Diastereoisomer
Pale-yellow solid; mp 161–164 °C.
GCMS (EI): m/z (%) = 224 (100) [M+ – SO2], 223 (45), 209 (72),
195 (25), 181 (55), 166 (35), 165 (45), 152 (17), 115 (16), 91 (9), 77
(8).
IR (neat): 2959, 1436, 1262, 1225, 1020, 882, 703, 697 cm–1.
Anal. Calcd for C16H16O3S: C, 66.64; H, 5.59; O, 16.64; S, 11.12.
Found: C, 66.67; H, 5.51; O, 16.83; S, 11.03.
1H NMR (300 MHz, CDCl3): d = 7.65–7.50 (m, 2 H, ArH), 7.45–
7.00 (m, 9 H, ArH), 6.64 (s, 1 H, ArH), 6.30 (s, 1 H, OCHS), 5.69
(s, 1 H, ArCHAr), 1.33 (s, 9 H, t-Bu), 1.07 (s, 9 H, t-Bu).
13C NMR (100 MHz, CDCl3): d = 152.2 (C), 142.5 (C), 141.3 (C),
138.8 (C), 137.9 (C), 129.1 (CH), 128.8 (CH), 128.60 (CH), 128.58
(CH), 127.7 (CH), 126.5 (CH), 124.4 (CH), 123.5 (C), 122.9 (CH),
82.8 (CH), 48.9 (CH), 35.3 (C), 34.3 (C), 31.4 (CH3), 30.2 (CH3).
Acknowledgment
We wish to thank Dr B. Rotzinger for PP-stabilization measure-
ments and Dr A. W. Thomas for useful comments during the prepa-
ration of the manuscript.
Synthesis 2009, No. 22, 3848–3852 © Thieme Stuttgart · New York